Lineage Cell Therapeutics (LCTX) EBITDA Margin Growth (3y) (2013 - 2026)
Lineage Cell Therapeutics (LCTX) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | -16,180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,180.00 |
| Dec 31, 2025 | 58,539.00 |
| Sep 30, 2025 | 7,230.00 |
| Jun 30, 2025 | -62,238.00 |
| Mar 31, 2025 | -31,096.00 |
| Dec 31, 2024 | -12,170.00 |
| Sep 30, 2024 | 19,984.00 |
| Jun 30, 2024 | 96,612.00 |
| Mar 31, 2024 | 134,178.00 |
| Dec 31, 2023 | 135,221.00 |
| Sep 30, 2023 | 63,964.00 |
| Jun 30, 2023 | 150,277.00 |
| Mar 31, 2023 | 116,871.00 |
| Dec 31, 2022 | 20,706.00 |
| Sep 30, 2022 | 131,021.00 |
| Jun 30, 2022 | 129,609.00 |
| Mar 31, 2022 | 125,298.00 |
| Dec 31, 2021 | 127,690.00 |
| Sep 30, 2021 | 75,323.00 |
| Jun 30, 2021 | -102,380.00 |